Location History:
- Foster City, CA (US) (2014)
- San Francisco, CA (US) (2001 - 2019)
Company Filing History:
10 out of 105 
3 out of 923 
1 out of 257 
Years Active: 2001-2019
Title: The Innovative Contributions of Andrew A. Wolff
Introduction
Andrew A. Wolff is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of medicine, particularly in the treatment of ALS and diabetes. With a total of 18 patents to his name, Wolff's work has the potential to impact the lives of many individuals suffering from these conditions.
Latest Patents
One of Wolff's latest patents is a method for treating ALS. This innovative approach involves administering a therapeutically effective amount of riluzole and CK-2017357 to a subject. The patent also outlines methods for reducing the variability of riluzole exposure, decreasing the total daily dose, increasing the half-life of riluzole, and minimizing adverse events associated with its use. Additionally, he has developed methods for treating diabetes, which focus on lowering plasma levels of HbA1c, glucose, total cholesterol, and triglycerides while increasing HDL cholesterol levels. These methods aim to delay the onset of diabetic retinopathy in various subjects while minimizing undesirable side effects.
Career Highlights
Wolff has worked with notable companies, including Cv Therapeutics, Inc. His experience in the pharmaceutical industry has equipped him with the knowledge and skills necessary to innovate in the field of medical treatments.
Collaborations
Throughout his career, Wolff has collaborated with talented individuals such as Fiona Baker and John Richard Langridge. These partnerships have likely contributed to the success of his inventions and patents.
Conclusion
Andrew A. Wolff's contributions to medical innovation, particularly in ALS and diabetes treatment, showcase his dedication to improving patient outcomes. His extensive patent portfolio reflects his commitment to advancing healthcare solutions.